We have found that from 8 patients that have been administered direct acting antivirals like Sovaldi, Harvoni and Epclusa, herpes virus became reactive in hepatitis C patients.
The hepatitis C patients were given direct acting antivirals from June 2016 to July 2017. 100 patients were in the sample at Qena University Hospital in Egypt.
If the reactivation of herpes virus in 8 patients, then its a chance of 8% reactivation of the herpes virus with hepatitis C.
More thorough studies and samples have to be performed for this data to be conclusive. Six patients were given sofosbuvir ledipasvir combination to treat hepatitis C, while the other two patients were given sofosbuvir daklinza combination.
For those looking for hepatitis C treatment we urge you to visit https://sunnypharma for all direct acting antiviral hepatitis C treatment.
